搜尋結果
3 天前 · 引发 2019冠状病毒病 的 严重急性呼吸综合征冠状病毒2 （SARS-CoV-2冠状病毒）容易发生突变而产生 變異株 （英语：Variant (biology)） ，关键病毒蛋白的突变即可能意味着其出现，目前已有多个变异株在世界各地形成并传播。. 由于病毒的 核酸 序列变异有 ...
3 天前 · 引發 嚴重特殊傳染性肺炎 的 嚴重急性呼吸道症候群冠狀病毒2型 （SARS-CoV-2冠狀病毒）容易發生突變而產生 變異株 （英語：Variant (biology)） ，關鍵病毒蛋白的突變即可能意味著其出現，目前已有多個變異株在世界各地形成並傳播。. 由於病毒的 核酸 ...
3 天前 · The SARS-related coronavirus was one of several viruses identified by the World Health Organization (WHO) in 2016 as a likely cause of a future epidemic in a new plan developed after the Ebola epidemic for urgent research and development before and during an epidemic towards diagnostic tests, vaccines and medicines.
6 天前 · Spike (S) glycoprotein (sometimes also called spike protein, [2] formerly known as E2 [3]) is the largest of the four major structural proteins found in coronaviruses. [4] The spike protein assembles into trimers that form large structures, called spikes or peplomers, [3] that project from the surface of the virion.
1 天前 · The Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield [31] and Vaxzevria [1] [32] among others, is a viral vector vaccine for the prevention of COVID-19. It was developed in the United Kingdom by Oxford University and British-Swedish company AstraZeneca , [33] [34] [35] using as a vector the modified chimpanzee adenovirus ChAdOx1 . [36]
- AU: B1
- SARS-CoV-2
- Vaxzevria, Covishield
- Viral vector
3 天前 · 50–70% of hospitalised COVID-19 cases, 10–30% of non-hospitalised cases, and 10–12% of vaccinated cases [3] Long COVID or long-haul COVID is a group of health problems persisting or developing after an initial period of COVID-19 infection. Symptoms can last weeks, months or years and are often debilitating. [3]
3 天前 · COVID-19, highly contagious respiratory illness, the cause of the COVID-19 pandemic. COVID-19 is caused by the coronavirus known as SARS-CoV-2. There is no cure for COVID-19, but individuals can be protected against severe illness through vaccination. Learn about the symptoms, treatment, and prevention of COVID-19.
